Impact of Specialty Pharmacy on Telaprevir-Containing 3-Drug Hepatitis C Regimen Persistence

BACKGROUND: Although the recommended treatment of hepatitis C continues to evolve as newer and more effective medications are made available, hepatitis C drug regimens consisting of a 3-drug combination of a protease inhibitor, pegylated interferon, and ribavirin were recommended by the American Ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Henderson, Rochelle R., Visaria, Jay, Bridges, Gail G., Dorholt, Mary, Levin, Rebecca J., Frazee, Sharon Glave
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441027/
https://www.ncbi.nlm.nih.gov/pubmed/25443516
http://dx.doi.org/10.18553/jmcp.2014.20.12.1227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441027/
https://www.ncbi.nlm.nih.gov/pubmed/25443516
http://dx.doi.org/10.18553/jmcp.2014.20.12.1227

Ejemplares similares